We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00571415
Recruitment Status : Terminated (Due to competing studies no further subjects could be recruited.)
First Posted : December 12, 2007
Last Update Posted : June 1, 2016
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Virginia Commonwealth University

Brief Summary:
Within this study patient data are collected from different imaging and motion monitoring devices that will be used to develop and test strategies for image-guided adaptive radiotherapy in cervix cancer patients.

Condition or disease
Cervix Cancer

Study Type : Observational
Actual Enrollment : 21 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Study Start Date : March 2009
Primary Completion Date : May 2013
Study Completion Date : October 2015

Group/Cohort
cervix cancer patients



Primary Outcome Measures :
  1. Increase in therapeutic ratio [ Time Frame: 5 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
University hospital clinic
Criteria

Inclusion Criteria:

  • Histological diagnosis of cervix cancer
  • Prescription of radiation treatment to the primary cancer

Exclusion Criteria:

  • Prior radiation treatment to the pelvis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00571415


Locations
United States, Virginia
Viriginia Commonwealth University, Department of Radiation Oncology
Richmond, Virginia, United States, 23298
Sponsors and Collaborators
Virginia Commonwealth University
National Cancer Institute (NCI)
Investigators
Principal Investigator: Jeffrey F Williamson, PhD Virginia Commonwealth University, Department of Radiation Oncology
Study Director: Jeffrey F Williamson, PhD VCU, Richmond, VA

Responsible Party: Virginia Commonwealth University
ClinicalTrials.gov Identifier: NCT00571415     History of Changes
Other Study ID Numbers: HM10390
P01CA116602 ( U.S. NIH Grant/Contract )
First Posted: December 12, 2007    Key Record Dates
Last Update Posted: June 1, 2016
Last Verified: May 2016

Keywords provided by Virginia Commonwealth University:
Image guided adaptive radiotherapy

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female